Skip to main content
Earnings Labs
Corvus Pharmaceuticals, Inc. logo

Corvus Pharmaceuticals, Inc. (CRVS) Earnings

NASDAQ·Healthcare·Biotechnology

$10.54

+0.72%

Mkt Cap $886.63M

EPS — Estimate vs Actual

Mkt Cap

$886.63M

P/E

—

Fwd P/E

—

P/S

—

Rev TTM

—

EPS TTM

-$0.55